SCHEMBL6068151

SCHEMBL6068151

Oc1ccc(-c2ccc(Cl)cc2)c(O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.62
MAPT P10636 4/20 0.62
KMT2A Q03164 4/20 0.62
ALOX15 P16050 3/20 0.62
ALOX12 P18054 3/20 0.62
CYP1A2 P05177 2/20 0.62
CYP3A4 P08684 2/20 0.62
CYP2D6 P10635 2/20 0.62
CYP2C9 P11712 2/20 0.62
CYP2C19 P33261 2/20 0.62
HSD17B10 Q99714 2/20 0.62
USP2 O75604 1/20 0.62
ALOX5 P09917 2/20 0.61
HTT P42858 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
GAA P10253 1/20 0.53
MAPK1 P28482 1/20 0.53
GPR55 Q9Y2T6 1/20 0.53
ESR1 P03372 2/20 0.51
ESR2 Q92731 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL28101908 0.98 MEN1 (0.60) MEN1MAPTKMT2AALOX15ALOX12
Ethane SCHEMBL28177585 0.96 MEN1 (0.58) MEN1MAPTKMT2AALOX15ALOX12
SCHEMBL28016335 0.86 HSD17B10 (0.54) MEN1MAPTKMT2AALOX15ALOX12
SCHEMBL278379 0.85 ALOX5 (0.73) HSD17B10ALOX5ESR1ESR2
SCHEMBL6030259 0.84 PIM1 (0.54) MEN1MAPTKMT2AALOX15ALOX12
SCHEMBL3811869 0.83 ALOX5 (0.70) MEN1KMT2AHSD17B10ALOX5ESR1
SCHEMBL15596256 0.81 ESR1 (0.61) MEN1MAPTKMT2AALOX15ALOX12
SCHEMBL1243182 0.81 MEN1 (0.53) MEN1MAPTKMT2AALOX15ALOX12
SCHEMBL29381883 0.81 MEN1 (0.53) MEN1MAPTKMT2AALOX15ALOX12
SCHEMBL580776 0.81 MEN1 (0.53) MEN1MAPTKMT2AALOX15ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
EP-1392673-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2004-03-03 EP disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed
WO-2002096901-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2002-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 MEN1 3850/4885MAPT 1176/4885KMT2A 2168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.